Markets

Market Nav

News Details

25/07/2025 17:38

Marksans Pharma - Board Meeting Outcome for Outcome For Consideration And Re-Appointment Of Mr. Mark Saldanha Subject To The

The Board in its meeting held today recommended the re-appointment of Mr. Mark Saldanha subject to the approval of the shareholders at the ensuing Annual General Meeting